Search
3283 results
-
Every year, European countries celebrate European Organ Donation Day (EODD). The idea behind this Day, initiated by the Council of Europe, is to encourage debate and provide information on organ, tissues and cells donation and transplantation, and legal and medical measures so that every European can decide about donation and make their wishes known to their family. Organ, tissues and cells transplantation is one of the great medical success stories of modern times and is the only life-saving treatment for end-stage organ failure in many conditions.
-
With a view to improving the correspondence between liquid chromatography column brand names (provided in the Knowledge Database) and the reagents used to describe the stationary phases for these columns, an overall review of all the monographs concerned has been launched. The names of the reagents and their definitions have also been reviewed to ensure that these stationary phases are described as clearly and consistently as possible.
-
L’EDQM annonce la mise à disposition des produits suivants : 18 lots de remplacement d’étalons de référence de la Pharmacopée Européenne (Ph. Eur.).
-
The EDQM announces the availability of 18 replacement batches for European Pharmacopoeia (Ph. Eur.) reference standards.
-
L’EDQM lancera prochainement une version remaniée et améliorée de sa plateforme de vente en ligne des étalons de référence, donnant ainsi suite à la récente enquête de satisfaction menée auprès de ses clients.
-
The EDQM will soon be launching a new and improved WebStore for Reference Standards, following up on its most recent customer satisfaction survey.
-
The EDQM has established a business continuity plan to anticipate and mitigate risks of disruption to our activities, so that the standards necessary for the production and release of medicines by pharmaceutical manufacturers and for market surveillance testing by official medicines control laboratories are available also during this pandemic. To protect the health of staff and the public, all EDQM staff that are not essential to conduct experimental or physical operations on site have been working remotely since 16 March. The tools and measures, which we have implemented, have proven to be efficient, enabling us to provide our services even under the current difficult circumstances. All our operations are currently running at regular capacity and our business continuity measures are being continually monitored and adapted, if necessary.
-
Les activités fondamentales de l’EDQM consistent à fournir des normes documentaires et physiques (étalons de référence) permettant d’assurer la qualité des médicaments et de leurs ingrédients. Dans le contexte de la pandémie en cours de COVID-19, la disponibilité de médicaments de qualité et l’accès des patients à ces médicaments revêtent plus que jamais une importance majeure.
-
The EDQM has established a business continuity plan to anticipate and mitigate risks of disruption to our activities, so that the standards necessary for the production and release of medicines by pharmaceutical manufacturers and for market surveillance testing by official medicines control laboratories are available also during this pandemic. To protect the health of staff and the public, all EDQM staff that are not essential to conduct experimental or physical operations on site have been working remotely since 16 March. The tools and measures, which we have implemented, have proven to be efficient, enabling us to provide our services even under the current difficult circumstances. All our operations are currently running at regular capacity and our business continuity measures are being continually monitored and adapted, as necessary.
-
The EDQM’s core activities include the provision of documentary and physical (reference) standards to ensure the quality of medicines and their ingredients. Availability of and access for patients to quality medicines is more important than ever in the context of the current COVID-19 pandemic.